Apollomics Future Growth
Future criteria checks 2/6
Apollomics's earnings are forecast to decline at 8.4% per annum while its annual revenue is expected to grow at 56.4% per year. EPS is expected to grow by 7.8% per annum.
Key information
-8.4%
Earnings growth rate
7.8%
EPS growth rate
Biotechs earnings growth | 24.0% |
Revenue growth rate | 56.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 01 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -145 | -146 | N/A | 1 |
12/31/2025 | 1 | -95 | -93 | N/A | 1 |
12/31/2024 | 1 | -63 | -56 | N/A | 2 |
12/31/2023 | 1 | -173 | -43 | -43 | N/A |
9/30/2023 | 1 | -280 | -45 | -45 | N/A |
6/30/2023 | 1 | -388 | -48 | -47 | N/A |
3/31/2023 | 1 | -314 | -45 | -45 | N/A |
12/31/2022 | 0 | -241 | -43 | -43 | N/A |
9/30/2022 | 0 | -136 | -42 | -41 | N/A |
6/30/2022 | 1 | -32 | -40 | -39 | N/A |
3/31/2022 | 1 | -63 | -45 | -41 | N/A |
12/31/2021 | 0 | -95 | -51 | -43 | N/A |
12/31/2020 | 2 | -75 | -46 | -36 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: APLM is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: APLM is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: APLM is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: APLM's revenue (56.4% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: APLM's revenue (56.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if APLM's Return on Equity is forecast to be high in 3 years time